Overexpression of a set of genes, including WISP-1, common to pulmonary metastases of both mouse D122 Lewis lung carcinoma and B16-F10.9 melanoma cell lines

British Journal of Cancer

Volumn 89, Issue 2, 2003, Pages 314-319

  Margalit, O ^a,b   Eisenbach, L ^c   Amariglio, N ^a,b   Kaminski, N ^a,b   Harmelin, A ^c   Pfeffer, R ^a,b   Shohat, M ^d   Rechavi, G ^a,b   Berger, R ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^d RABIN MEDICAL CENTER   (Israel)

Author keywords

B16 F10.9 melanoma; D122 Lewis lung carcinoma; DNA microarrays; Gene expression; Metastasis; WISP 1

Indexed keywords

ARGINASE; BRAIN NATRIURETIC PEPTIDE; INTERLEUKIN 1ALPHA; OLIGONUCLEOTIDE; PLASMINOGEN ACTIVATOR INHIBITOR 2; SECRETORY PROTEIN; SURFACTANT PROTEIN C; UNCLASSIFIED DRUG; UTEROGLOBIN; WNT 1 INDUCED SECRETED PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LINE; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENETICS; LEWIS CARCINOMA; LUNG METASTASIS; MALE; MELANOMA CELL; MINIMAL RESIDUAL DISEASE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UNINDEXED SEQUENCE;

ANIMALS; CARCINOMA, LEWIS LUNG; CARRIER PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GROWTH SUBSTANCES; HUMANS; LUNG NEOPLASMS; MALE; MELANOMA; MICE; MICE, INBRED C57BL; NEOPLASM METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEINS; PLASMINOGEN ACTIVATOR INHIBITOR 2; POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED; UTEROGLOBIN;

EID: 0042121086     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600977     Document Type: Article

References (41)

1. Affymetrix (1998) Eukaryotic Expression Analysis Target Preparation. Santa Clara, CA: Affymetrix
2. Andreasen PA, Egelund R, Petersen HH (2000) The plasminogen activation system in tumor growth, invasion, and metastasis. Cell Mol Life Sci 57: 25-40
3. Andreasen PA, Kjöller L, Christensen L, Duffy MJ (1997) The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 72: 1-22
4. Borstnar S, Vrhovec I, Svetic B, Cufer T (2002) Prognostic value of the urokinase-type plasminogen activator, and its inhibitors and receptor in breast cancer patients. Clin Breast Cancer 3: 138-146
5. Cavanaugh PG, Nicolson GL (2000) Partial purification of a liver-derived tumor cell growth inhibitor that differentially inhibits poorly-liver metastasizing cell lines: identification as an active subunit of arginase. Clin Exp Metastasis 18: 509-518
6. Chang CI, Liao JC, Kuo L (2001) Macrophage arginase promotes tumor cell growth and suppresses nitric oxide-mediated tumor cytotoxicity. Cancer Res 61: 1100-1106
7. Chen JJ, Peck K, Hong TM, Yang SC, Sher YP, Shih JY, Wu R, Cheng JL, Roffler SR, Wu CW, Yang PC (2001) Global analysis of gene expression in invasion by a lung cancer model. Cancer Res 61: 5223-5230
8. Chen Z, Colon I, Ortiz N, Callister M, Dong G, Pegram MY, Arosarena O, Strome S, Van Waes C (1998) Effects of IL-1α, IL-1RA and neutralizing antibody on proinflammatory cytokine expression by human squamous cell carcinoma lines. Cancer Res 58: 3668-3676
9. Chen Z, Malhotra PS, Thomas GR, Ondrey FG, Duffey DC, Enamorada I., Mousa S, Van Waes C (1999) Expression of proinflammatory and proangiogenic cytokines in human head and neck patients. Clin Cancer Res 5: 1369-1379
10. Clark EA, Golub TR, Lander ES, Hynes RO (2000) Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406: 532-535
11. Cowie MR, Mendez GF (2002) BNP and congestive heart failure. Prog Cardiovasc Dis 44: 293-321
12. Eisen MB, Spellman PT, Brown PO, Botstein D (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95: 14863-14868
13. Eisenbach L, Segal S, Feldman M (1983) MHC imbalance and metastatic spread in Lewis lung carcinoma clones. Int J Cancer 32: 113-120
14. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell 69: 119-128
15. Gehlsen KR, Argraves WS, Piersbacher MD, Ruoslahti E (1988) Inhibition of in vitro cell invasion by Arg-Gly-Asp-containing peptides. J Cell Biol 106: 925-930
16. Gemma A, Takenaka K, Hosoya Y, Matuda K, Seike M, Kurimoto F, Ono Y, Uematsu K, Takeda Y, Hibino S, Yoshimura A, Shibuya M, Kudoh S (2001) Altered expression of several genes in highly metastatic subpopulations of a human pulmonary adenocarcinoma cell line. Eur J Cancer 37: 1554-1561
17. Ginzinger D (2002) Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. Exp Hematol 30: 503-512
18. Grandis JR, Melhem MF, Gooding WE, Day R, Hoist VA, Wagener MM, Drenning SD, Tweardy DJ (1998) Levels of TGF-α and EGFR protein in head and neck squamous cell carcinoma and patient survival. J Natl Cancer Inst 90: 824-832
19. Hashimoto Y, Shindo-Okada N, Tani M, Nagamachi Y, Takeuchi K, Shiroishi T, Toma H, Yokota J (1998) Expression of the Elm1 gene, a novel gene of the CCN (connective tissue growth factor, Cyr61/Cef10, and neuroblastoma overexpressed gene) family, suppresses In vivo tumor growth and metastasis of K-1735 murine melanoma cells. J Exp Med 187: 289-296
20. Jain M, Arvanitis C, Chu K, Dewey W, Leonhardt E, Trinh M, Sundberg CD, Bishop JM, Felsher DW (2002) Sustained loss of a neoplastic phenotype by brief inactivation of MYC. Science 297: 102-104
21. Khanna C, Khan J, Nguyen P, Prehn J, Caylor J, Yeung C, Trepel J, Meltzer P, Helman L (2001) Metastasis-associated differences in gene expression in a murine model of osteosarcoma. Cancer Res 61: 3750-3759
22. Lauri D, Bertomeu MC, Orr FW, Bastida E, Sauder D, Buchanan MR (1990) Interleukin-1 increases tumor cell adhesion to endothelial cells through an RGD dependent mechanism: in vitro and in vivo studies. Clin Exp Metastasis 8: 27-32
23. Liotta LA, Steeg PS, Stetler-Stevenson WG (1991) Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327-336
24. Ohsaki Y, Gross AJ, Le PT, Oie H, Johnson BE (1999) Human small cell lung cancer cells produce brain natriuretic peptide. Oncology 56: 155-159
25. Pelengaris S, Khan M, Evan GI (2002) Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. Cell 109: 321-334
26. Pennica D, Swanson TA, Welsh JW, Roy MA, Lawrence DA, Lee J, Brush J, Taneyhill LA, Deuel B, Lew M, Watanabe C, Cohen RL, Melhem MF, Finley GG, Quirke P, Goddard AD, Hillan KJ, Gurney AL, Botstein D, Levine AJ (1998) WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc Natl Acad Sci USA 95: 14717-14722
27. Porgador A, Feldman M, Eisenbach L (1989) H-2Kb transfection of B16 melanoma cells results in reduced tumorigenicity and metastatic competence. J Immunogenet 16: 291-303
28. Robert C, Bolon I, Gazzeri S, Veyrenc S, Brambilla C, Brambilla E (1999) Expression of plasminogen activator inhibitors 1 and 2 in lung cancer and their role in tumor. Clin Cancer Res 5: 2094-2102
29. Salden M, Splinter TA, Peters HA, Look MP, Timmermans M, van Meerbeeck JP, Foekens JA (2000) The urokinase-type plasminogen activator system in resected non-small-cell lung cancer. Ann Oncol 11: 327-332
30. Schmitt M, Harbeck N, Thomssen C, Wilhelm O, Magdolen V, Reuning U, Ulm K, Höfler H, Jänicke F, Graeff H (1997) Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy. Thromb Haemost 78: 285-296
31. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88: 593-602
32. Singh R, Pervin S, Karimi A, Cederbaum S, Chaudhuri G (2000) Arginase activity in human breast cancer cell lines: N(omega)-hydroxy-L-arginine selectively inhibits cell proliferation and induces apoptosis in MDA-MB-468 cells. Cancer Res 60: 3305-3312
33. Su F, Overholtzer M, Besser D, Levine AJ (2002) WISP-1 attenuates p53-mediated apoptosis in response to DNA damage through activation of the Akt kinase. Genes Dev 16: 46-57
34. Szabo E, Goheer A, Witschi H, Linnoila RI (1998) Overexpression of CC10 modifies neoplastic potential in lung cancer cells. Cell Growth Differ 9: 475-485
35. Tomimatsu S, Ichikura T, Mochizuki H (2001) Significant correlation between expression of interleukin-1 alpha and liver metastasis in gastric carcinoma. Cancer 91: 1272-1276
36. Van Waes C, Kozarsky KF, Warren AB, Kidd L, Paugh D, Liebert M, Carey TE (1991) The A9 antigen associated with aggressive human squamous carcinoma is structurally and functionally similar to the newly defined integrin α6 β4. Cancer Res 51: 2395-2402
37. Van Waes C, Surh DM, Chen Z, Rhim JS, Brager R, Roy SB, Kashima H, Wolf GT, Carey TE (1995) Increase in suprabasilar integrin adhesion molecule expression in human epidermal neoplasms accompanies increased proliferation occurring with immortalization and tumor progression. Cancer Res 55: 5434-5444
38. Van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-536
39. Workman P, Twentyman P, Balkwill F, Balmain A, Chaplin D, Double J, Embleton J, Newell D, Raymond R, S, Stephens T, Wallace J (1998) United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia. Br J Cancer 77: 1-10
40. Xie D, Nakachi K, Wang H, Elashoff R, Koeffler HP (2001) Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features. Cancer Res 61: 8917-8923
41. Xu L, Corcoran RB, Welsh JW, Pennica D, Levine AJ (2000) WISP-1 is a Wnt-1- and beta-catenin-responsive oncogene. Genes Dev 14: 585-595